Table 1.
Summary of patient clinical information.
| No. | Gender | Age | Disease duration (years) | Side* | Disease stage** | UPDRS motor subscale | ACE-R (MMSE) | LDE *** |
|---|---|---|---|---|---|---|---|---|
| 1 | M | 63 | 11 | R | 1.5 | 16 | 94 (29) | 1315 |
| 2 | M | 74 | 16 | L | 2 | 19 | 98 (30) | 620 |
| 3 | M | 81 | 15 | L | 2.5 | 20 | 94 (29) | 410 |
| 4 | M | 54 | 15 | L | 1 | 26 | 89 (29) | 1815 |
| 5 | M | 56 | 11 | R | 3 | 14 | 86 (29) | 1210 |
| 6 | F | 73 | 13 | B | 2.5 | 13 | 95 (28) | 565 |
| 7 | F | 76 | 9 | R | 3 | 13 | 91 (30) | 855 |
| 8 | F | 81 | 13 | L | 2 | 16 | 97 (29) | 1355 |
| 9 | M | 77 | 13 | L | 2 | 37 | 97 (30) | 1720 |
| 10 | M | 64 | 6 | L | 1.5 | 15 | 94 (29) | 1175 |
| 11 | M | 48 | 6 | R | 2.5 | 24 | 88 (29) | 535 |
| 12 | M | 72 | 26 | L | 1 | 21 | 85 (28) | 460 |
| 13 | M | 57 | 14 | B | 1 | 21 | 94 (28) | 1180 |
| 14 | F | 66 | 17 | L | 2 | 21 | 95 (27) | 1740 |
| 15 | M | 76 | 12 | L | 1 | 31 | 87 (27) | 1500 |
| 16 | F | 64 | 11 | B | 3 | 19 | 96 (28) | 1000 |
| 17 | M | 77 | 9 | L | 3 | 18 | 88 (27) | 700 |
| 18 | F | 55 | 8 | L | 2 | 16 | 98 (29) | 200 |
| Average | 67 | 13 | 2 | 20 | 93 (29) | 1020 | ||
UPDRS = Unified Parkinson’s Disease Rating Scale; MMSE = Mini-Mental State Examination; ACE-R = Addenbrooke’s Cognitive Examination Revised; LDE = Levodopa dose equivalent; *Dominant side of motor symptoms: L = left, R = right, B = bilateral. **According to Hoehn and Yahr, 1967; ***Calculated according to Tomlinson et al.29.